As he noted in an interview with RIA Novosti, all volunteers participating in the study have already been vaccinated: 75% - with the vaccine, 25% received a placebo.
“At the end of April, preliminary results will be summed up for all eight centers where post-registration studies are carried out.
Until that time, it is premature to talk about concrete figures, ”he said.
Maksyutov said that the study is being conducted among 3 thousand volunteers.
All have already passed 42 days after the injection of the drug.
It is noted that the total duration of observation of volunteers will be 180 days.
Earlier, the head of Vector told about the peculiarities of revaccination with EpiVacCorona.